Morphological features of doxorubicin-resistant Walker 256 carcinosarcoma and response of mast cells

Background: The mechanisms of drug resistance of cancer have not been yet elucidated in details. Recently, the role of mast cells (MCs) in the development of drug resistance has been brought in the limelight. The aim of the study was to examine the morphological features of doxorubicin (DOX)-resista...

Full description

Saved in:
Bibliographic Details
Published in:Experimental Oncology
Date:2018
Main Authors: Boroday, N.V., Chekhun, V.F.
Format: Article
Language:English
Published: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2018
Subjects:
Online Access:https://nasplib.isofts.kiev.ua/handle/123456789/139246
Tags: Add Tag
No Tags, Be the first to tag this record!
Journal Title:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Cite this:Morphological features of doxorubicin-resistant Walker 256 carcinosarcoma and response of mast cells / N.V. Boroday, V.F. Chekhun // Experimental Oncology. — 2018 — Т. 40, № 1. — С. 42-47. — Бібліогр.: 30 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine
id nasplib_isofts_kiev_ua-123456789-139246
record_format dspace
spelling Boroday, N.V.
Chekhun, V.F.
2018-06-19T21:04:01Z
2018-06-19T21:04:01Z
2018
Morphological features of doxorubicin-resistant Walker 256 carcinosarcoma and response of mast cells / N.V. Boroday, V.F. Chekhun // Experimental Oncology. — 2018 — Т. 40, № 1. — С. 42-47. — Бібліогр.: 30 назв. — англ.
1812-9269
https://nasplib.isofts.kiev.ua/handle/123456789/139246
Background: The mechanisms of drug resistance of cancer have not been yet elucidated in details. Recently, the role of mast cells (MCs) in the development of drug resistance has been brought in the limelight. The aim of the study was to examine the morphological features of doxorubicin (DOX)-resistant Walker 256 carcinosarcoma and to assess the response of MCs and histamine content in these cells in relation to the development of resistance to DOX as well as in DOX-resistant tumors. Materials and Methods: The DOX resistance was induced by serial passages of Walker 256 carcinosarcoma in rats in the setting of DOX treatment in vivo. MCs in tumors were detected in the sections by staining with Toluidine Blue O. Histamine content in MCs stained with solution of Water Blue-Orcein was assessed by Astaldi semiquantitative method taking into account different staining intensity. Results: Formation of DOX resistance in the course of serial passages of Walker 256 carcinosarcoma was accompanied by the increase in the number of MCs in tumors and histamine content. Nevertheless, in tumors with phenotype of complete DOX resistance the number of histamine-containing MCs decreased to the same level as in tumors of the original strain that are DOX-sensitive. Conclusion: MCs are involved in formation of DOX resistance in Walker 256 carcinosarcoma.
en
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
Experimental Oncology
Original contributions
Morphological features of doxorubicin-resistant Walker 256 carcinosarcoma and response of mast cells
Article
published earlier
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
collection DSpace DC
title Morphological features of doxorubicin-resistant Walker 256 carcinosarcoma and response of mast cells
spellingShingle Morphological features of doxorubicin-resistant Walker 256 carcinosarcoma and response of mast cells
Boroday, N.V.
Chekhun, V.F.
Original contributions
title_short Morphological features of doxorubicin-resistant Walker 256 carcinosarcoma and response of mast cells
title_full Morphological features of doxorubicin-resistant Walker 256 carcinosarcoma and response of mast cells
title_fullStr Morphological features of doxorubicin-resistant Walker 256 carcinosarcoma and response of mast cells
title_full_unstemmed Morphological features of doxorubicin-resistant Walker 256 carcinosarcoma and response of mast cells
title_sort morphological features of doxorubicin-resistant walker 256 carcinosarcoma and response of mast cells
author Boroday, N.V.
Chekhun, V.F.
author_facet Boroday, N.V.
Chekhun, V.F.
topic Original contributions
topic_facet Original contributions
publishDate 2018
language English
container_title Experimental Oncology
publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
format Article
description Background: The mechanisms of drug resistance of cancer have not been yet elucidated in details. Recently, the role of mast cells (MCs) in the development of drug resistance has been brought in the limelight. The aim of the study was to examine the morphological features of doxorubicin (DOX)-resistant Walker 256 carcinosarcoma and to assess the response of MCs and histamine content in these cells in relation to the development of resistance to DOX as well as in DOX-resistant tumors. Materials and Methods: The DOX resistance was induced by serial passages of Walker 256 carcinosarcoma in rats in the setting of DOX treatment in vivo. MCs in tumors were detected in the sections by staining with Toluidine Blue O. Histamine content in MCs stained with solution of Water Blue-Orcein was assessed by Astaldi semiquantitative method taking into account different staining intensity. Results: Formation of DOX resistance in the course of serial passages of Walker 256 carcinosarcoma was accompanied by the increase in the number of MCs in tumors and histamine content. Nevertheless, in tumors with phenotype of complete DOX resistance the number of histamine-containing MCs decreased to the same level as in tumors of the original strain that are DOX-sensitive. Conclusion: MCs are involved in formation of DOX resistance in Walker 256 carcinosarcoma.
issn 1812-9269
url https://nasplib.isofts.kiev.ua/handle/123456789/139246
citation_txt Morphological features of doxorubicin-resistant Walker 256 carcinosarcoma and response of mast cells / N.V. Boroday, V.F. Chekhun // Experimental Oncology. — 2018 — Т. 40, № 1. — С. 42-47. — Бібліогр.: 30 назв. — англ.
work_keys_str_mv AT borodaynv morphologicalfeaturesofdoxorubicinresistantwalker256carcinosarcomaandresponseofmastcells
AT chekhunvf morphologicalfeaturesofdoxorubicinresistantwalker256carcinosarcomaandresponseofmastcells
first_indexed 2025-12-02T04:24:54Z
last_indexed 2025-12-02T04:24:54Z
_version_ 1850861484071976960